Katie Herman

Conference Coverage

CancerLinQ Technology in the Oncology Community

10/17/2022

Robert S. Miller, MD, FACP, FASCO, FAMIA, Chief Medical Science Officer, CancerLinQ, American Society of Clinical Oncology, described how data aggregation and analytic platforms are aiding in clinical decision support and explained current...

Robert S. Miller, MD, FACP,...

10/17/2022

Journal of Clinical Pathways

Conference Coverage

Cost-Effectiveness Analyses of Ibrutinib vs Acalabrutinib vs Zanubrutinib as First-line Treatment in Patients With Chronic Lymphocytic Leukemia

12/12/2022

Katie Herman ;

At the 64th ASH Annual Meeting and Exposition, Neda Alrawashdh, PharmD, presented a network meta-analysis of three BTKis in terms of progression-free survival in support of cost-effectiveness analyses from the US payer perspective.

At the 64th ASH Annual Meeting...

12/12/2022

Journal of Clinical Pathways

Conference Coverage

Therapeutic Interchange Reduces Cost While Maintaining Quality of Care in the US Oncology Care Model

10/01/2022

Katie Herman ;

At the 2022 ASCO Quality Care Symposium, Ives and colleagues concluded that therapeutic interchange is an effective way to reduce total cost of care while maintaining the quality of care in the Oncology Care Model.

At the 2022 ASCO Quality Care...

10/01/2022

Journal of Clinical Pathways

Conference Coverage

Hospital Costs and Health Care Resource Utilization for Chimeric Antigen T-Cell Therapy and Stem Cell Transplant in Patients with Large B-Cell Lymphoma in the United States

12/12/2022

Katie Herman ;

At the 64th ASH Annual Meeting and Exposition, Gunjan L Shah, MD, described and compared hospital costs and health care resource utilization of chimeric antigen T-cell therapy and stem cell transplant for the procedure, preprocedure, and...

At the 64th ASH Annual Meeting...

12/12/2022

Journal of Clinical Pathways

Conference Coverage

Optimizing Oncology Care in Older Adults

10/15/2022

Craig Ostroff ;

Katie Herman ;

Kjel A. Johnson, PharmD, Vice President, Specialty Product Strategy CVS Health, presented at the 2022 Oncology Clinical Pathways Congress regarding optimizing patient care in older adults from an operational and integrational perspective.

Kjel A. Johnson, PharmD, Vice...

10/15/2022

Journal of Clinical Pathways

Conference Coverage

HER2-Low Breast Cancer in the National Cancer Database

12/09/2022

Katie Herman ;

Daniel Peiffer, MD, PhD, and colleagues discuss a retrospective cohort study comparing clinical characteristics and demographics of HER2-0 vs HER2-low cases.

Daniel Peiffer, MD, PhD, and...

12/09/2022

Journal of Clinical Pathways

Conference Coverage

Low-Value Care Directly Leads to Development of Cancer Genomic Pathways

10/16/2022

Katie Herman ;

Craig Ostroff ;

Tatjana Kolevska, MD, explains at the 2022 Oncology Clinical Pathways Conference that digital pathways are the way of the future in regard to cancer care.

Tatjana Kolevska, MD, explains...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

Precision Medicine and AI in Oncology Patient Care

10/16/2022

Katie Herman ;

Craig Ostroff ;

Tushar Pandey, CEO, SimBioSys, Inc, in his 2022 Oncology Clinical Pathways Congress presented on the value artificial intelligence brings to oncology patient care, and the need to move to guided intelligence.

Tushar Pandey, CEO, SimBioSys,...

10/16/2022

Journal of Clinical Pathways

Conference Coverage

HER2-Positive Metastatic Breast Cancer Treatment Patterns in Patients Who Have Received at Least Two Lines of Therapy

12/07/2022

Katie Herman ;

Della Varghese, PharmD, PhD, and colleagues presented a poster at the 2022 San Antonio Breast Cancer Symposium studying second-line (2L) treatment patterns and outcomes among HER2+ metastatic breast cancer (mBC) patients in the United States.

Della Varghese, PharmD, PhD, and...

12/07/2022

Journal of Clinical Pathways

Conference Coverage

Gene Sequencing in the Clinic

10/16/2022

Katie Herman ;

Craig Ostroff ;

Mahek Shah, MD, MBA, MS, at the 2022 Oncology Clinical Pathways Congress, discussed the need to enable gene sequencing-as-a-service in clinical settings and what that means for future clinical care.

Mahek Shah, MD, MBA, MS, at the...

10/16/2022

Journal of Clinical Pathways